结核分枝杆菌感染风险的性别差异:基于人群免疫反应性调查的系统综述与Meta分析
该系统综述与Meta分析纳入1993年1月1日至2022年12月31日高结核发病率地区的人群结核分枝杆菌免疫反应性调查,共80项研究81次调查、38个国家、478968名参与者。结果显示儿童期性别差异小,青春期后男性免疫反应性转换率更高,各年龄组男性与女性患病率比随年龄增加。
要点
- 儿童(<10岁)男性与女性结核分枝杆菌免疫反应性患病率比为0.95(95%可信区间0.90-1.01)。
- 30岁时男性免疫反应性转换率约为女性的1.4倍。
- 10-19岁、20-39岁、≥40岁男性与女性患病率比分别为1.07、1.13、1.28。
核心结论
- 男性结核分枝杆菌免疫反应性风险高于女性,可能是全球结核病发病率和死亡率性别差异的关键驱动因素。
- 该差异可能源于社会和行为差异导致在结核传播的聚集性室内空间停留时间更长,男性传染期更长进一步放大,以及年龄和性别 assortative mixing。
- 针对男性结核分枝杆菌暴露决定因素的公共卫生干预对终结结核病流行至关重要。
研究设计与样本
- 系统综述与Meta分析,检索Embase、Global Health、Science Citation Index Expanded和Global Index Medicus,纳入1993年1月1日至2022年12月31日高结核发病率地区样本量至少150人的人群结核分枝杆菌免疫反应性调查。
- 纳入横断面调查、干预或队列研究的基线调查以及病例对照研究的对照组(具人群代表性)。
- 提取按性别和年龄组分层的免疫反应性患病率数据,构建贝叶斯分层模型分析年龄和性别的患病率及男性与女性患病率比,并分析地区、结核发病率和研究年份等协变量。
- 研究注册于PROSPERO(CRD42022360483)。
主要发现
- 筛查26517项研究,167项符合纳入标准;80项研究(81次调查)提供性别分层结果,来自38个国家,共478968名参与者。
- 儿童(<10岁)男性与女性免疫反应性患病率比为0.95(95%可信区间0.90-1.01)。
- 青春期后男性免疫反应性转换率高于女性,30岁时为女性的1.4倍。
- 10-19岁、20-39岁和≥40岁男性与女性免疫反应性患病率比分别为1.07(95%可信区间1.01-1.13)、1.13(1.06-1.20)和1.28(1.19-1.37)。
- 成年男性在不同环境中结核分枝杆菌患病率一致较高,男性与女性患病率比的异质性低。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Tuberculosis killed 1·25 million people globally in 2023. Men have a 1·7 times higher tuberculosis incidence than women, but it is not known to what extent this discrepancy is driven by greater exposure to Mycobacterium tuberculosis. We aimed to analyse the effect of age and sex on M tuberculosis immunoreactivity. METHODS: In this systematic review and meta-analysis, we reviewed Embase, Global Health databases, Science Citation Index Expanded, and Global Index Medicus for population-based M tuberculosis immunoreactivity (with interferon-γ release assay or skin test) surveys done in high tuberculosis incidence settings from Jan 1, 1993, to Dec 31, 2022, with a sample size of at least 150 people. We included cross-sectional surveys, baseline surveys for interventional or cohort studies, and control groups of case-control studies with population-representative groups. We extracted data on M tuberculosis immunoreactivity prevalence, disaggregated by sex and age group. We constructed Bayesian hierarchical models, first of immunoreactivity prevalence by age and sex and second of the male-to-female (M:F) prevalence ratio by age. We analysed the effect of covariables including region, tuberculosis incidence, and study year. This study was registered on PROSPERO (CRD42022360483). FINDINGS: We screened 26 517 studies, of which 167 met our inclusion criteria. Sex-disaggregated results were available from 80 studies (81 surveys), from 38 different countries, comprising data from 478 968 participants. We found little sex difference in M tuberculosis immunoreactivity in childhood (M:F prevalence ratio for children younger than 10 years was 0·95; 95% credible interval 0·90-1·01). However, from adolescence onwards, men experienced higher immunoreactivity conversion than women (1·4 times higher by age 30 years). This higher conversion rate cumulatively drove a higher immunoreactivity prevalence in men, with a prevalence ratio of 1·07 (95% credible interval 1·01-1·13) in those aged 10-19 years, 1·13 (1·06-1·20) in those aged 20-39 years, and 1·28 (1·19-1·37) for those aged 40 years and older. Adult men had consistently higher M tuberculosis prevalence across different settings, with low between-study heterogeneity in M:F prevalence ratio. INTERPRETATION: Men have higher M tuberculosis immunoreactivity risk than women, which is likely to be a key driver of the sex differences in global tuberculosis morbidity and mortality. This difference could be due to higher exposure through social and behavioural differences in time spent in congregate indoor spaces where tuberculosis transmission occurs, further amplified by longer duration of infectiousness in men, and age-assortative and sex-assortative mixing. Public health interventions addressing men's determinants of M tuberculosis exposure will be crucial to ending the tuberculosis epidemic. FUNDING: Wellcome Trust and UK Foreign, Commonwealth & Development Office.
引用
- Rickman HM, Phiri MD, Feasey HRA, et al. Sex differences in the risk of Mycobacterium tuberculosis infection: a systematic review and meta-analysis of population-based immunoreactivity surveys. Lancet Public Health. 2025. PMID: 40602858. doi:10.1016/S2468-2667(25)00120-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。